Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Dugas

Showing results (301-310 of 337) with videos related to

Pageof 34
Sort By:
Journal of Medical Internet Research|February 24, 2026
Quality of Life Trajectories With Integration Into Electronic Health Records for High-Resolution Patient Outcomes: Algorithm Development and Validation StudyMartin Dugas, Robin Fleige, Max Christian Blumenstock, et al.
Nature Medicine|March 13, 2012
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemiaTino Schenk, Weihsu Claire Chen, Stefanie Göllner, et al.
The EMBO Journal|August 31, 2016
Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitorsPia Riemke, Melinda Czeh, Josephine Fischer, et al.
Neuro-Oncology|November 11, 2020
An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastomaThomas K Albert, Marta Interlandi, Martin Sill, et al.
Leukemia|June 21, 2020
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapyMaxi Wass, Stefanie Göllner, Birgit Besenbeck, et al.
Blood|May 26, 2010
Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemiaCarsten Müller-Tidow, Hans-Ulrich Klein, Antje Hascher, et al.
BMJ Open|September 11, 2025
Heidelberg Perioperative Deep Data Study (HeiPoDD): study protocol for a prospective cohort study for prediction of complications after high-risk non-cardiac surgery in a German university hospitalMona Jung-König, Hans Thomas Hölzer, Solveig Tenckhoff, et al.
Blood|December 31, 2011
Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor geneShuchi Agrawal-Singh, Fabienne Isken, Konstantin Agelopoulos, et al.
Nature Communications|March 23, 2022
Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumorsMonika Graf, Marta Interlandi, Natalia Moreno, et al.
British Journal of Haematology|July 9, 2023
Dose-dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9-induced leukaemic cellsPradeep Kumar Patnana, Longlong Liu, Daria Frank, et al.
Pageof 34

Showing results (301-310 of 337) with videos related to

Sort By:
Pageof 34
Journal of Medical Internet Research|February 24, 2026
Quality of Life Trajectories With Integration Into Electronic Health Records for High-Resolution Patient Outcomes: Algorithm Development and Validation StudyMartin Dugas, Robin Fleige, Max Christian Blumenstock, et al.
Nature Medicine|March 13, 2012
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemiaTino Schenk, Weihsu Claire Chen, Stefanie Göllner, et al.
The EMBO Journal|August 31, 2016
Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitorsPia Riemke, Melinda Czeh, Josephine Fischer, et al.
Neuro-Oncology|November 11, 2020
An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastomaThomas K Albert, Marta Interlandi, Martin Sill, et al.
Leukemia|June 21, 2020
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapyMaxi Wass, Stefanie Göllner, Birgit Besenbeck, et al.
Blood|May 26, 2010
Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemiaCarsten Müller-Tidow, Hans-Ulrich Klein, Antje Hascher, et al.
BMJ Open|September 11, 2025
Heidelberg Perioperative Deep Data Study (HeiPoDD): study protocol for a prospective cohort study for prediction of complications after high-risk non-cardiac surgery in a German university hospitalMona Jung-König, Hans Thomas Hölzer, Solveig Tenckhoff, et al.
Blood|December 31, 2011
Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor geneShuchi Agrawal-Singh, Fabienne Isken, Konstantin Agelopoulos, et al.
Nature Communications|March 23, 2022
Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumorsMonika Graf, Marta Interlandi, Natalia Moreno, et al.
British Journal of Haematology|July 9, 2023
Dose-dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9-induced leukaemic cellsPradeep Kumar Patnana, Longlong Liu, Daria Frank, et al.
Pageof 34